Small and Smaller—sRNAs and MicroRNAs in the

Regulation of Toxin Gene Expression in Prokaryotic

Cells: A Mini-Review by Bloch, Sylwia et al.
toxins
Review
Small and Smaller—sRNAs and MicroRNAs in the
Regulation of Toxin Gene Expression in Prokaryotic
Cells: A Mini-Review
Sylwia Bloch 1, Alicja We˛grzyn 2, Grzegorz We˛grzyn 1 and Boz˙ena Nejman-Falen´czyk 1,*
1 Department of Molecular Biology, University of Gdan´sk, Wita Stwosza 59, 80-308 Gdan´sk, Poland;
sylwia.bloch@biol.ug.edu.pl (S.B.); grzegorz.wegrzyn@biol.ug.edu.pl (G.W.)
2 Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Wita Stwosza 59, 80-308 Gdan´sk,
Poland; alicja.wegrzyn@biol.ug.edu.pl
* Correspondence: bozena.nejman@ug.edu.pl; Tel.: +48-058-523-6038
Academic Editor: Vernon L. Tesh
Received: 7 April 2017; Accepted: 26 May 2017; Published: 30 May 2017
Abstract: Non-coding small RNAs (sRNAs) have been identified in the wide range of bacteria
(also pathogenic species) and found to play an important role in the regulation of many processes,
including toxin gene expression. The best characterized prokaryotic sRNAs regulate gene expression
by base pairing with mRNA targets and fall into two broad classes: cis-encoded sRNAs (also called
antisense RNA) and trans-acting sRNAs. Molecules from the second class are frequently considered
as the most related to eukaryotic microRNAs. Interestingly, typical microRNA-size RNA molecules
have also been reported in prokaryotic cells, although they have received little attention up to now.
In this work we have collected information about all three types of small prokaryotic RNAs in the
context of the regulation of toxin gene expression.
Keywords: prokaryotes; non-coding small RNAs; microRNAs; toxin gene expression
1. Introduction
The first hypothesis about the regulatory role of RNA molecules on the level of gene expression
appeared in 1961 and was proposed by two outstanding scientists Francois Jacob and Jacques
Monod [1]. This theory was quickly forgotten as many protein regulators were found in both
prokaryotes and eukaryotes. Fortunately, it has aroused renewed interest in recent years. Over
the last two decades an explosion in the study of RNA regulators, including non-coding small phage
and bacterial RNAs (sRNAs), has been observed. Although a few hundred sRNAs have been predicted
in the genome of Escherichia coli, one of the best-studied bacterial models, only about 100 have been
experimentally validated up to now [2]. Interestingly, the majority of known E. coli sRNAs also occur
in other, closely-related bacterial species. These molecules have been identified in a wide range of
bacteria, including pathogens like Salmonella and Yersinia, and found to play an important role in the
regulation of many processes such as carbon metabolism, virulence, motility, quorum sensing, biofilm
formation, bacterial adaptation to changing conditions, and response to stresses [2–6]. The small
RNAs occurring in prokaryotic cells vary in size between 50 and 500 nucleotide in length, show
high structural diversity, and exhibit different molecular mechanisms of action. The most intensively
studied prokaryotic sRNA regulators act by base pairing and share either extensive (cis-acting sRNAs)
or more limited (trans-acting sRNAs) complementarity with their target transcripts [3].
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In this work we gather information about two of the groups of small prokaryotic RNAs indicated
above involved in the regulation of toxin gene expression. In addition, (for the first time in the review)
we direct attention to microRNA-size molecules identified in prokaryotic cells, and present the outcome
of the feature comparison between these and the above-mentioned cis-, and trans-acting sRNAs
molecules (Table 1). We discuss the contribution of all these three types of sRNAs in the regulation
of prokaryotic-cell based production of toxins. For transparency and clarity of the data presented
in particular sections, we review separately sRNAs originating from the bacterial chromosome and
molecules encoded within horizontally acquired genetic elements, with a particular focus on phage
encoded sRNAs. In this report it was important to emphasize the significance of small RNAs molecules
originating from phage genomes, as not enough attention has yet been given to this topic.
2. Prokaryotic Small RNAs (sRNAs) in the Context of the Regulation of Toxin Gene Expression
2.1. cis-Encoded sRNAs
The first group of small prokaryotic RNAs contains true antisense RNAs, which are synthesized
from the complementary strand, at the same genetic locus as the target mRNA they regulate (Figure 1a).
The overlap may occur at either the 5′ end or 3′ end of the mRNA transcript. It happens that the
overlap includes the whole or fragments of the designated open reading frame [7]. The majority
of cis-encoded sRNAs have broad secondary structures with very long stems and low numbers
of unpaired nucleotides. In many cases these sRNAs have extensive complementarity (above
60 nucleotides) with their targets and pair rapidly. It helps to pair unstable RNAs and minimize
the possibility of the RNAs’ dissociation. Usually, such an interaction does not require the presence
of a chaperone like Hfq protein. However, additional protein factors might be involved to increase
the specificity and efficiency of this regulation [8]. Antisense sRNAs are found mainly in phages and
plasmids, although they also occur on bacterial chromosomes [7,8]. For clarity, some features essential
for cis-acting sRNAs are summarized in Table 1, whereas examples of cis-acting sRNA-mediated
regulations of toxin production are described below and listed in Table 2.
Table 1. Comparison of the main features of three types of prokaryotic non-coding sRNAs.
Feature cis-Acting sRNAs trans-Encoded sRNAs MicroRNA-SizedMolecules
Action on the target gene
Complementarity with
targets One or multiple
targets Accompanying
proteins Structure
Processing
cis-regulation extensive
one usually not required
broad secondary
structures with very long
stems does not occur
trans-regulation limited
multiple usually
required more loosely
structures with shorter
stems usually does
not occur 2
trans-regulation
limited multiple 1
not determined
usually single
stem-loop precursor
structure occur 3
The most common size
range of the mature sRNA
molecule (nt)
50–100 50–100 15–26
1 Multiple targets have been predicted but not confirmed experimentally; 2 In a few cases processing from
longer RNA to a shorter fragment occurs [9,10]. However, mature molecules are still longer than typical,
approximately 20-nucleotide microRNAs; 3 The mechanism of processing from precursors to shorter forms has not
yet been determined.
Toxins 2017, 9, 181 3 of 13Toxins 2017, 9, 181 3 of 12 
 
 
Figure 1. Schematic presentation of the three groups of small non-coding RNAs: (a) cis-encoded, (b) trans-encoded, and (c) microRNA-size molecules involved in 
the regulation of toxin gene expression in prokaryotic cells. Regulatory non-coding RNAs are shown in grey, whereas target mRNAs are shown in black. Size ranges 
of the respective types of non-coding RNAs are indicated in brackets and cover lengths most frequently reported in the literature.
Figure 1. Schematic presentation of the three groups of small non-coding RNAs: (a) cis-encoded, (b) trans-encoded, and (c) microRNA-size molecules involved in the
regulation of toxin gene expression in prokaryotic cells. Regulatory non-coding RNAs are shown in grey, whereas target mRNAs are shown in black. Size ranges of
the respective types of non-coding RNAs are indicated in brackets and cover lengths most frequently reported in the literature.
Toxins 2017, 9, 181 4 of 13
Table 2. Examples of cis-acting, trans-encoded and microRNA-size non-coding RNA molecules
involved in the regulation of toxin production and secretion by prokaryotic cells.
sRNA Type sRNA Name sRNA Source sRNA Function in the Context of theRegulation of Toxin Production and Secretion Ref.
cis-encoded
sRNAs
OOP Bacteriophage λ
Is predicted to repress the synthesis of the cII
protein and thus indirectly regulate the
production of Shiga toxins by Stx phages
[11,12]
Sok Plasmid R1 &chromosome of E. coli
Indirectly inhibits the synthesis of the highly
toxic protein Hok, responsible for cell
membrane damage
[13]
Rdl Chromosome of E. coli Regulates the synthesis of the Ldr toxin, whoseover expression leads to rapid host cell killing [13]
SymR Chromosome of E. coli Regulates the endogenous level of theSymE toxin [13]
trans-encoded
sRNAs
IsrK Bacteriophage Gifsy-1
Controls the production of the toxic AntQ
protein which is responsible for bacterial growth
arrest and cell death
[14]
RNAIII Chromosome ofStaphylococcus aureus
Induces the expression of genes encoding the
staphylococcal alpha-toxin [15]
FasX Chromosome ofStreptococcus pyogenes
Positively controls the production of
streptococcal haemolytic exotoxin
streptolysin S (SLS)
[16]
VR-RNA Chromosome ofClostridium perfringens
Is responsible for the regulation of the expression
of toxin genes, such as plc (α toxin phospholipase
C) and colA, (κ toxin, collagenase)
[17]
VirX Chromosome ofClostridium perfringens
Regulates the expression of genes : plc, colA and
pfoA coding for pore-forming toxin
perfringolysin A; Controls the production
of enterotoxin
[18]
VirU Chromosome ofClostridium perfringens
Has a positive effect on the production of
pore-forming toxin perfringolysin A [18]
VirT Chromosome ofClostridium perfringens Negatively regulates pfoA and colA transcription [18]
IstR-1 Chromosome of E. coli
Inhibits translation of the toxic protein TisB,
which is responsible for cell growth arrest under
stress conditions
[19]
microRNA-size
RNAs
24B_1 Bacteriophage Φ24B
Is predicted to regulate the phage d_ant gene,
and thus indirectly stimulate the lysogenic state
of the Stx phage during which Shiga toxins are
not produced
[20]
MM-H Chromosome ofMycobacterium marinum Does not have a defined function [21]
AA_20050
PG_122
TD_16563
Chromosome of
Aggregatibacter
actinomycetemcomitans,
Porphyromonas gingivalis,
Treponema denticola
Do not have defined functions and are
transmitted by outer membrane vesicles (OMVs)
that enable bacteria to secrete a large, complex
group of proteins, including toxins
[22]
Most of the chromosomally, cis-encoded bacterial sRNAs have been reported to repress genes
that encode small toxic proteins. Such an interaction has been classified in literature as the type I
toxin-antitoxin (TA) pair [8]. The best known mechanism of the repression of toxic protein synthesis by
antisense RNA assumes that sRNA base pairs across the ribosome binding site and blocks translation
and/or provokes the mRNA degradation. Obviously, in some cases this regulation is more complex [8].
The Hok-Sok system of E. coli is one of the best characterized TA systems at present. This system
is localized on the R1 plasmid, although the E. coli chromosome contains six homologous hok/sok
loci. Additional homologs have also been found on the F plasmid (SrnB-SrnC) and R483 plasmid
(PndA-PndB) [13]. Data have shown that a small antisense RNA (Sok) represses the synthesis of a small,
hydrophobic protein (Hok) that kills the host cell by damaging the bacterial cell membrane, although
it does not overlap the hok Shine-Dalgarno sequence. Instead, Sok RNA competes with a ribosome for
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the ribosome binding site of a neighbouring open reading frame mok, which almost entirely overlaps
and is translationally coupled to that of the hok. As a result, Sok RNA indirectly inhibits the translation
of hok mRNA by preventing the translation of mok [13]. Another type I toxin-antitoxin system has
been identified on the E. coli chromosome within long direct repeat (LDR) sequences. This system
includes protein toxin Ldr and RNA antitoxin Rdl. Overexpression of the small Ldr toxin leads to rapid
host cell killing. In turn, cis-acting sRNA, named SymR is encoded opposite to the 5′ untranslated
region of symE mRNA. SymE toxin synthesis might be induced during SOS response, and is strongly
repressed at multiple levels including SymR RNA, which acts at the level of mRNA stability and
translation [13,23]. Toxins regulated by sRNAs are likely to be integral membrane proteins. They
are mostly hydrophobic, predicted to contain helical transmembrane domains and frequently similar
to bacteriophage holin proteins. Even in small amounts they may cause damage to the bacterial
membrane, and high levels lead to cell death. Other effects of protein toxins such as disruption of
the nucleoid structure, chromosome segregation or cell division have also been observed. Antisense
sRNA-based repression of toxin synthesis which occurs at the mRNA level and prevents production
of toxic proteins, may have particular benefits. Contrary to antitoxin proteins which may dissociate
from target toxins, the action of antitoxin sRNAs is usually irreversible as target mRNA is degraded.
Besides, by preventing toxin production the cell reduces energy costs [8].
Among phage derived cis-acting sRNAs, one of the first described was the 77-nt molecule named
OOP RNA, of bacteriophage λ [11]. This sRNA has been known for over 40 years and is encoded on
the strand opposite to the strand of the cII-O transcript [24]. The OOP RNA-dependent cleavage of
the cII mRNA was found to have physiological significance and to stimulate the lytic development
of the λ bacteriophage [12,25]. Importantly, sequences similar to λ OOP RNA have been found in the
cII-O regions of Shiga toxin-converting bacteriophages (Stx phages), responsible for the virulence of
enterohaemorrhagic E. coli (EHEC) strains [12]. These pathogens cause serious food poisoning with
bloody diarrhoea in humans. Their main virulence factors are Shiga toxins, encoded by genes stx1 and
stx2 located in the late region of the genome of the temperate bacteriophage, which occurs in bacteria
as a prophage and is able to undergo both a lysogenic cycle and a lytic cycle. Lysogeny is one of the
two phases of the temperate phage life cycle, characterized by the integration of phage nucleic acid into
the bacterial genome to form a prophage, and by inhibition of the expression of the majority of phage
genes. In such conditions bacteria grow and proliferate normally while phage DNA is replicating
together with the bacterial genome and is transmitted to daughter cells during cell division. In this
state, phage can be maintained for many cell generations. In the case of lamboid phages, to which
Stx phages belong, the prophage state is achieved through the repression of the main lytic promoters,
pL and pR, by binding of the phage cI repressor. As long as cI is active, the prophage is maintained,
and production of majority of phage-derived proteins is suppressed. Many phage proteins, including
Shiga toxins, whose genes are located on Stx prophages, are repressed in the lysogeny state, and
their production occurs only after prophage induction. This step leads irreversibly to phage lytic
development, host cell lysis and liberation of progeny virions [26,27]. The progressively produced
Shiga toxins cause bloody diarrhoea—the first symptom of human infection [28,29]. The impact of
Stx OOP RNAs on stx genes’ expression and thus production of Shiga toxins may be considered on
the basis of their contribution in the regulation of the phage lytic cycle. Other examples of phage
cis-encoded antisense RNAs have been found in virulent bacteriophage PAK_P3 during the early stage
of infection of Pseudomonas aeruginosa bacteria. It was hypothesized that these antisense sRNAs may
negatively impact the expression of late phage genes during the initial stage of infection, although this
function has not been determined [30]. The presence of antisense RNAs expressed from the genome of
bacteriophage φR1-37, infecting selected strains of Yersinia enterocolitica, has also been confirmed [31].
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2.2. trans-Encoded sRNAs, Resembling Eukaryotic Small RNAs
The second group includes sRNAs, broadly described by Wagner and Romby [32], that also act
by pairing, but have limited complementarity with their target mRNAs and are usually found at
genomic locations remote from those of their targets (Figure 1b). In comparison with cis-acting sRNAs,
they possess looser structures with shorter stems and higher numbers of unpaired nucleotides [3,8].
In addition, unlike cis-encoded sRNAs, small RNAs from this group usually have more than one
mRNA target, and their pairing with targets frequently involves a highly-conserved seed region of
6–8 contiguous nucleotides (Table 1). For example, the widely conserved GcvB small RNA is able
to regulate up to ~1% of all mRNAs in the Gram-negative bacteria species Salmonella typhimurium
and E. coli [3,7,32]. In this light, trans-encoded RNA are often considered as the most related to
eukaryotic microRNAs and siRNAs, and, similarly to them, they are able to regulate the translation
and stability of target mRNAs. In addition to some common features, they differ in the details of
their biogenesis and presentation on a protein scaffold. Trans-encoded bacterial sRNAs are generally
transcribed as single transcripts, approximately 100 nucleotides in length and, unlike eukaryotic
microRNAs and siRNAs, they are not processed to shorter fragments around 20-nt long. Interestingly,
prokaryotic sRNAs derived by processing from longer RNAs also occur, although they are still longer
than typical eukaryotic microRNAs and siRNAs [9,10]. Their transcription terminates frequently
with a Rho-independent terminator, and the transcript is folded into a stable stem-loop structure
which probably helps to keep stability. As indicated, trans-encoded sRNAs are more stable than their
mRNA targets. In most cases these sRNAs, without further processing, bind to the Hfq chaperone
which stabilizes sRNA and facilitates its base pairing with target mRNAs [7,33]. This protein is
highly-conserved in prokaryotes. However, not all bacterial genomes contain the hfq homologue.
Although the majority of E. coli trans-encoded sRNAs act by base pairing associated by the Hfq protein,
some, such as sRNAs from other bacteria, e.g., Vibrio cholerae, Listeria monocytogenes, do not require
this chaperone, even if Hfq is present in the host organism [34]. For comparison, the biogenesis of
eukaryotic microRNA occurs through a multi-step process during which the primary microRNA
(pri-microRNA) transcript, which can have from 10s to 100s of kilobases in length [35], undergoes
subsequent enzymatic cuts to create a short microRNA duplex about 22 nucleotides in length. Next,
one strand of this RNA duplex is incorporated into the RNA-induced silencing complex (RISC) where
the mature microRNA interacts with its mRNA target [36]. Although both prokaryotic and eukaryotic
small RNAs need protein cofactors which help in their presentation to the target mRNAs, the protein
scaffold is more complex in the case of eukaryotic microRNAs. Another difference between bacterial
trans-encoded sRNAs and the microRNAs of eukaryotes is the position of sRNA binding within the
target mRNA transcript. In bacterial sRNAs, the overlap occurs frequently at the 5′ end of the target
mRNAs, whereas eukaryotic microRNAs pair mainly at the 3′ untranslated region of the mRNAs.
Base pairing between the prokaryotic trans-encoded sRNAs and mRNAs usually leads to mRNA
degradation and/or translation blocking, but may also result in translation stimulation [33]. A brief
overview of trans-encoded sRNA-based regulations of toxin production in prokaryotic cells is described
below and presented in Table 2.
One of the best known examples of E. coli sRNA-mediated regulation is the translation of the
transcription factor RpoS (an alternative sigma factor of prokaryotic RNA polymerase), which is
negatively influenced by the OxyS sRNA and positively regulated by at least two other small bacterial
RNAs, DsrA, and RprA. Both of them pair with the region upstream of the translation start site
and block the formation of a cis-inhibitory hairpin structure [37]. It was thought previously that the
activation of translation by small RNAs is unique to prokaryotes [23]. However, as shown recently,
eukaryotic microRNAs are also able to positively regulate translation [38,39]. Interestingly, trans-acting
sRNAs (both positively and negatively impacted translation) have been recognized as essential factors
involved in virulence regulation in many prokaryotic pathogens [2]. For instance, RNAIII, one
of the largest known regulatory RNAs from Staphylococcus aureus, is a bifunctional molecule that
encodes the δ-haemolysin protein in its 5′ end and additionally acts as a non-coding regulatory
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trans-encoded RNA. As indicated, this molecule can stimulate the translation of the staphylococcal
alpha-toxin and regulate several other mRNAs with implications in virulence control [15,40]. Other
interesting examples are trans-acting sRNAs named VR-RNA, VirX, VirU, and VirT encoded within
the genome of Clostridium perfringens. These sRNAs are able to regulate the expression of various
toxin genes, like plc (α toxin phospholipase C), colA, (κ toxin, collagenase), or pfoA (pore-forming toxin
perfringolysin A), in different ways. However, their molecular mechanisms of gene regulation are still
not understood [15,17,18]. Another molecule, FasX, was reported to have regulatory properties and
to positively control the production of streptococcal haemolytic exotoxin streptolysin S (SLS) [15,16].
In some cases the antitoxin RNAs are also encoded in trans. One such example is identified in E. coli
small RNA, named IstR-1. This molecule works as an antitoxin and inhibits the translation of the toxic
protein TisB, which is an SOS-induced toxin that arrests cell growth under stress conditions [19].
A global study searching for small RNAs of phage origin was conducted by Tree and collaborators
in 2014 [41]. They identified fifty-five Hfq-interacting sRNAs within phage-derived regions of the
EHEC genome. Thirty-one of them were predicted to carry Rho-independent terminators. One of
the best characterized molecules from this group is AgvB. This sRNA acts in a non-standard manner
and mimics the mRNA target (DppA) of other small RNAs encoded in the bacterial chromosome and
named GcvB. In detail, small RNA AgvB and DppA mRNA compete for binding to the Hfq protein
and thereby also to GcvB. In this way AgvB antagonizes the functions of GcvB and, as indicated, aids
the growth of Shiga toxin—producing E. coli bacteria within their animal host. Another small RNA,
encoded by a prophage present in the genome of EHEC bacteria, has been identified by Sudo and
collaborators [42]. This molecule is called Esr41, and was detected as an approximately 70-nucleotide
long transcript with a predicted Rho-independent terminator and Hfq-interacting structure. Esr41
is classified as a trans-encoded sRNA and may regulate the expression of many genes from the
bacterial motility regulation network, including fliC, which encodes the major subunit of flagella.
Interestingly, the sequence of Esr41 is also present in Shigella bacteria [42]. Phage-derived small
RNAs (~100 nt) have also been found at high levels in both a lysogen and during the late lytic
cycle of mycobacteriophage, Giles [43]. Furthermore, acting in trans IsrK sRNA has been identified
within the Gifsy-1 prophage of Salmonella bacteria. This molecule acts as small RNA to control the
production of the toxic AntQ protein, playing a significant role in bacterial growth arrest and cell
death [14]. Trans-encoded small RNAs have also been found in virulent bacteriophage PAK_P3,
infecting pathogenic Pseudomonas aeruginosa bacteria. Interestingly, the identified small RNAs are
strongly transcribed during late infection, but their role remains unclear [30]. An additional non-coding
intragenic RNA molecule of unknown function has been identified within the genome of the φR1-37
bacteriophage infecting some strains of Yersinia enterocolitica [31]. Molecules selected from these two
phages are the first examples of characterized small trans-acting RNAs encoded by virulent phages.
Potential targets for these molecules have been found on the genomes of phage hosts which are human
pathogens able to release dangerous toxins, although the functions of the identified molecules are not
yet understood.
3. Something Smaller than sRNAs—True MicroRNAs in Prokaryotic Cells
The term “small molecules with great possibilities” fits the short, about 20-nucleotide RNA
fragments, called microRNAs. Since the first such molecule was identified over 20 years ago in
1993 [44], a growing number of microRNAs have been found in humans, plants, and animals. Up to
2014, 24,521 microRNAs had been discovered, and they are important components of many regulatory
pathways [45]. Although such small molecules have been found broadly in multicellular organisms,
there is an opinion that typical prokaryotic microRNAs do not occur [46]. Interestingly, a few
microRNA-size small RNA fragments (15–26 nt) have recently been reported in prokaryotic cells.
Such prokaryotic RNAs of comparable size to eukaryotic microRNAs have received little attention up
to now and, therefore, they are presented in this section, summarized in Table 1 and schematically
illustrated in Figure 1c.
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So far, microRNA-size RNA fragments have been identified in a few different species of bacteria.
Such molecules were found in Streptococcus mutans in 2011 [47] and in E. coli in 2013 [48], although
their functions remain to be determined. Another microRNA of bacterial origin has been identified in
Mycobacterium marinum, a fish pathogen able to produce a unique mycolactone toxin, mycolactone
F [21]. This 23-nt small RNA molecule, named MM-H, is derived from a precursor stem-loop
structure, requires the mammalian host cell RNA processing machinery for its biogenesis, and probably
also affects the expression of the eukaryotic host, rather than bacterial genes [21]. Small RNAs
comparable in size to eukaryotic microRNAs have also been identified in periodontal pathogens such
as: leukotoxin LtxA—producing Aggregatibacter actinomycetemcomitans; engaged in the production
of the haemolytic toxin Porphyromonas gingivalis strain; responsible for production of highly toxic
metabolites Treponema denticola bacteria [22] and a key player in the colonization of the human oral
cavity Streptococcus sanguinis [49]. It was observed that the identified microRNA-size RNAs are secreted
from the periodontal pathogens via bacterial outer membrane vesicles (OMVs) and affect the eukaryotic
host immune system by suppressing the expression of certain cytokines [22]. Interestingly, OMVs
serve as secretory vehicles by which pathogens not only modulate the host immune response, but also
deliver toxins into host cells and are, thus, considered as a potent virulence mechanism [50]. In this
light, the identified microRNA-size molecules may function as novel bacterial signalling molecules that
mediate both the bacteria-eukaryotic host and bacteria-bacteria interactions during infection [21,22,49].
Our group presented the phage-derived microRNA-size (20-nt long) molecule which had been
isolated from E. coli culture after the induction of Shiga toxin-converting bacteriophage Φ24B, which
is responsible for the virulence of EHEC strains [20]. This small RNA, named 24B_1, is encoded in
the lom-vb_24B_43 region of the phage Φ24B genome. Apparently, it is produced by the cleavage of
a larger (80-nt long) transcript, which was also detected. Since it appeared quite abundant in the
next-generation sequencing analysis, we assume that 24B_1 is a product of the specific cleavage of the
longer transcript [20]. Additionally, using Mfold web server: 1995–2017 (hosted by the RNA Institute,
College of Arts and Sciences, State University of New York at Albany, NY, USA) we were able to
predict the hairpin RNA structure of the identified 80-nt transcript. As both the secondary structure of
the precursor and its cleavage to the shorter form resemble the formation of microRNAs in eukaryotic
cells [51], we suggest that 24B_1 might be formally considered as this type of sRNA. Additionally, in
silico analyses showed the presence of two potential binding sites for this molecule within the phage
genome. Interestingly, 24B_1 displays limited complementarity with both of the identified targets.
Apart from that, we have demonstrated that this small molecule has a physiological role and promotes
phage lysogeny—a part of the phage life cycle in which most of the phage genes are not expressed and
proteins are not produced. Such a conclusion is supported by results showing that the mutant phage
lacking the sequence encoding the whole precursor revealed dramatic changes in the expression of all
tested phage genes during E. coli infection, and significant differences in various phage developmental
processes [20]. As we know, 24B_1 is the first phage–derived microRNA-size RNA molecule identified
so far, and this is the first demonstration of the physiological significance of a phage microRNA-size
molecule in bacterial cells [20].
All the above-presented prokaryotic microRNA-size molecules [20–22,47–49] have been identified
by next generation sequencing (NGS). Such an experimental approach and bioinformatics analysis
allowed for extracting large amounts of data and the identification of, e.g., more than 400 [48] or
more than 900 [47] individual RNAs of microRNA size (15–26 nt) in a single experiment. Up to
now, the cellular abundance of about 30 molecules identified by NGS [20–22,47–49] was validated
experimentally, mainly by qRT-PCR and/or Northern blot techniques. Furthermore, in silico analyses
allowed for the prediction and presentation of a total of 24 hairpin-structured precursors for the
validated prokaryotic microRNA-size molecules [20–22,47–49]. Within that group, the expression
of seven longer, potential precursor transcripts, covering the predicted microRNAs loci, have been
confirmed in bacterial cells by the RT-PCR method [20,22]. The exact cleavage site of the identified
hairpin precursors are not yet confirmed. However, the presence of single, unsmeared bands of
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analysed microRNAs revealed by Northern blot [47,49] and the observation that they occur in NGS
data in only one fixed-length form [20] suggest that at least some of the found molecules may be a result
of the specific cut of the longer precursor. In the light of the current knowledge that the presence of a
longer hairpin precursor is crucial for the final processing of eukaryotic microRNAs [52], we suggest
that at least seven molecules discussed here might be considered as microRNA type molecules [20,22].
On the basis of the available knowledge, we cannot exclude that, similarly to eukaryotic microRNAs,
prokaryotic microRNAs undergo a multi-step maturation process. As a reminder, in the first step
of microRNA biogenesis in eukaryotic cells, RNA polymerase generates a very long pri-microRNA
transcript that can extend hundreds of kilobases in length. This pri-microRNA undergoes nuclear
cleavage, by the protein complex containing the Drosha enzyme, to form a short, about 70-nt, hairpin
structure known as precursor microRNA (pre-microRNA). This precursor RNA is then exported from
the nucleus by Exportin-5. In the cytoplasm, the pre-microRNA is processed by Dicer enzyme into a
mature molecule of about 22-nt miRNAs. As the Dicer enzyme seems to be essential for the maturation
of eukaryotic microRNAs, it was suggested that the same role may be served by the MazF enzyme in
E. coli bacteria [47]. Importantly, alternative Drosha- and Dicer-independent microRNA biogenesis
pathways have also been proposed in eukaryotes [53]. In the search for other similarities between
eukaryotic and prokaryotic microRNA-size molecules, attention has been attracted to the proposed
mechanism of microRNA transfer by OMVs [22,49]. Studies of bacterial OMVs have revealed some
similarities with exosomes involved in eukaryotic microRNAs transport [54]. It was proven that,
similarly to exosomal microRNAs, prokaryotic microRNA-size molecules found in OMVs are stable
and well protected from degradation by ribonucleases [22,49]. Additionally, by analogy to exosomal
microRNAs, it is possible to suggest a probable role of prokaryotic microRNAs as signalling molecules
involved in communication among prokaryotic cells and/or between prokaryotic and eukaryotic cells.
Importantly, such a signalling function can also be considered in the light of scientific data showing
that identified microRNAs may regulate the phage lifecycle [20], may suppress the expression of
certain cytokines [22], and may be involved in vitamin B12 conversion [49].
The question emerges of whether the identified microRNAs should be seen in the context of the
regulation of prokaryotic-cell based toxin production. It is difficult to answer this question clearly
now, as very little information is known about their function in prokaryotic cells. Nevertheless,
it seems likely—or at least it cannot be excluded, as some provided examples of microRNAs might be
considered in this context (Table 2). Our investigation has shown that microRNA-size molecule 24B_1
may act as a negative regulator of the expression of the d_ant gene which encodes an antirepressor of the
phage cI repressor, and thus indirectly stimulates the phage lysogenic state [20]. As cI is responsible for
maintaining the lysogenic life cycle, its deactivation results in prophage induction, production of phage
proteins (including toxins), and release of progeny phages. In the light of the ability of the identified
microRNA size 24B_1 molecule to control phage lysogeny, we may also consider this molecule in the
context of the regulation of Shiga toxins gene expression. It should, however, be emphasized that the
direct regulation of the expression of Shiga toxins genes by 24B_1 was not proven, and that, to our
knowledge, this is the first and only example of phage microRNA-dependent regulation of toxin gene
expression in bacterial cells [20]. Other identified examples of such regulation and further research
are required to confirm that this is a widespread phenomenon. However, in the frame of this work
we wanted to attract attention to this issue. This seems to be particularly important in view of the
well-recognized role of bacteriophages as vectors of bacterial toxins [55]. Several different types of
bacterial virulence factors, including not only Shiga, but also diphtheria, botulinum, cholera, and
other toxins, are encoded on a diversity of lysogenic phages, frequently tailed dsDNA phages [56].
In the light of the foregoing, we cannot exclude that other phage or bacterial origin microRNA-size
molecules affecting the regulation of toxin gene expression may be identified in the future. Bearing
in mind that eukaryotic microRNAs can regulate tens to hundreds of protein-coding genes, and a
single transcript can be regulated by several microRNAs of the same or different sequence [57,58], we
can speculate that microRNAs in prokaryotic cells present similar abilities, and would also be able to
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regulate multiple targets. If this is true, many biological processes, including toxins production, may
be largely influenced by microRNAs occurring in prokaryotic cells.
4. Conclusions
Many small non-coding RNAs have been identified as crucial regulatory elements in the virulence
of bacteria. A major class of prokaryotic sRNAs act by pairing with extensive or more limited
complementarity with their target transcripts. Trans-encoded sRNAs are the largest class of prokaryotic
non-coding RNAs, and for long time they have been considered as the equivalents of the eukaryotic
microRNAs and siRNAs. Although they resemble eukaryotic small RNAs in their biological effects,
they vary considerably in the details of their synthesis and presentation on a protein scaffold to
the target mRNAs [33]. The view that trans-acting sRNAs are the most related to eukaryotic small
RNAs is changing slightly since the true prokaryotic microRNAs have been reported [20–22,47–49].
Unquestionably, microRNAs identified so far in prokaryotic cells serve as the starting points for further
studies in this new, largely unexplored research area. In comparison to the very large number of
reports concerning eukaryotic microRNAs, current knowledge about such microRNAs in prokaryotic
systems is only ‘a drop in the ocean’ and there is an urgent need to continue research in this field.
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